ADVFN ADVFN

Hot Features

Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
International Stem Cell Corporation (QB)

International Stem Cell Corporation (QB) (ISCO)

0,17
0,00
(0,00%)
Fermé 23 Juin 10:00PM

International Stem Cell Corporation (QB) (ISCO) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
0,17
( - )
Prix Achat
0,15
Prix Vente
0,20
Volume échangé
1 010
0,17 Fourchette du Jour 0,20
0,11 Plage de 52 semaines 0,2726
Cap du marché
Clôture Veille
0,17
Ouverture
0,20
Dernière Transaction
500
@
0.17
Dernière heure de transaction
Volume financier
US$ 202
VWAP
0,20
Volume moyen (3 m)
US$ 5 433
Actions en circulation
8 004 389
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-3,39
Bénéfice par action (BPA)
-0,05
Chiffre d'affairess (LTM)
9,29M
Bénéfice net (LTM)
-382k

À propos de International Stem Cell Corporation (QB)

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC-hpNSC, a neural stem cell program that has completed the Phase I clinical trial for ... International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC-hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson’s disease, as well as for treating stroke, traumatic brain injury, and Alzheimer’s disease. The company offers anti-aging skin care products, including ProPlus Advanced Defense Complex, ProPlus Advanced Recovery Complex, ProPlus Eye Firming Complex, ProPlus Neck Firming Complex, ProPlus Advanced Aqueous Treatment, ProPlus Collagen Booster, ProPlus Elastin Booster, and ProPlus Brightening Toner. In addition, it provides human cell culture products comprising human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cells from the heart and blood vessels, and reagents to study cardiovascular disease and cancer; human bronchial and tracheal cell lines for the study of toxicity, cystic fibrosis, asthma, and pathogenesis; and human mammary epithelial cell lines for the study of breast cancer, three dimensional culture, and carcinogen screening. Its human cell culture products also consists of adult stem cells and reagents for regenerative medicine; human prostate cells and specialized medium to study prostate disease; human renal and bladder cells and media to study renal and bladder diseases; human corneal cells and media for the study of corneal disease; human female reproductive system cells for the study of cellular physiology; human skeletal muscle cells for the study of biology, diabetes, insulin receptor studies, muscle metabolism, muscle tissue repair, and myotube development; and other cell culture reagents and supplements for the growth, staining, and freezing of human cells. It serves professional and retail customers. The company was founded in 2001 and is headquartered in San Diego, California. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Siège social
San Diego, United States
Fondé
2026
International Stem Cell Corporation (QB) est coté dans le secteur Healthcare de la OTC Markets avec le ticker ISCO. Le dernier cours de clôture d'International Stem Cell (QB) était de US$0,17. Au cours de la dernière année, les actions de International Stem Cell (QB) ont été négociées dans une fourchette de prix de US$ 0,11 à US$ 0,2726.

International Stem Cell (QB) compte actuellement 8 004 389 actions en circulation. La capitalisation boursière d'International Stem Cell (QB) est de US$1,36 million. International Stem Cell (QB) a un ratio cours/bénéfice (ratio PE) de -3.39.

ISCO Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1000.170.20.1714000.17CS
4000.170.20.1713760.170685CS
120.016.250.160.21750.135128570.17178874CS
260.03525.92592592590.1350.21750.11773050.15294501CS
520.010856.817467797680.159150.27260.1171210.15045836CS
1560.0321.42857142860.140.27260.04652600.12823349CS
260-0.22-56.41025641030.390.80.04653910.28044451CS

ISCO - Frequently Asked Questions (FAQ)

What is the current International Stem Cell Corporation (QB) share price?
The current share price of International Stem Cell Corporation (QB) is US$ 0,17
How many International Stem Cell Corporation (QB) shares are in issue?
International Stem Cell Corporation (QB) has 8 004 389 shares in issue
What is the market cap of International Stem Cell Corporation (QB)?
The market capitalisation of International Stem Cell Corporation (QB) is USD 1,36M
What is the 1 year trading range for International Stem Cell Corporation (QB) share price?
International Stem Cell Corporation (QB) has traded in the range of US$ 0,11 to US$ 0,2726 during the past year
What is the PE ratio of International Stem Cell Corporation (QB)?
The price to earnings ratio of International Stem Cell Corporation (QB) is -3,39
What is the cash to sales ratio of International Stem Cell Corporation (QB)?
The cash to sales ratio of International Stem Cell Corporation (QB) is 0,15
What is the registered address of International Stem Cell Corporation (QB)?
The registered address for International Stem Cell Corporation (QB) is 9745 Businesspark Avenue, San Diego, California, 92131
What is the International Stem Cell Corporation (QB) website address?
The website address for International Stem Cell Corporation (QB) is www.internationalstemcell.com
Which industry sector does International Stem Cell Corporation (QB) operate in?
International Stem Cell Corporation (QB) operates in the Biotechnology & Life Sciences sector

ISCO Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock